This protocol is judged by an institutional assessment board, an impartial group that assessments any clinical trials involving human beings. If a analyze involves a Routine I drug, when the board approves the protocol as moral, the scientists need to submit an application for an investigational new drug (IND) number in the FDA.Some researchers an